I85PREP
⌘ K
Hospital Pharmacy (China) study materials
Hospital Pharmacy (China) study resources

Hospital Pharmacy (China) practice questions

One question at a time. Build your Hospital Pharmacy (China) understanding.

First 50 of 190 questions. Each one lists the choices, the correct answer, and an explanation. The checker at the top of this page saves progress in this browser when it is available.

Continue in the practice tool above to load more questions, 50 at a time.

Question 1Pharmacodynamic targets, class effects and therapeutic limits

Which adrenergic receptor subtype is predominantly located on bronchial smooth muscle and vascular smooth muscle of skeletal muscle, mediating relaxation and bronchodilation upon activation (支气管平滑肌舒张)?

  1. Alpha-1 adrenergic receptor (α1受体)
  2. Beta-1 adrenergic receptor (β1受体)
  3. Alpha-2 adrenergic receptor (α2受体)
  4. Beta-2 adrenergic receptor (β2受体) Correct answer.

Explanation

Beta-2 adrenergic receptors (β2受体) are coupled to Gs proteins, stimulating adenylate cyclase to increase intracellular cAMP, which activates protein kinase A (PKA) and promotes smooth muscle relaxation. Activation of β2 receptors produces bronchodilation, vasodilation in skeletal muscle vascular beds, and glycogenolysis in the liver.

Question 2Pharmacodynamic targets, class effects and therapeutic limits

Which biochemical pathway and specific fungal enzyme are targeted by triazole antifungal agents such as fluconazole and voriconazole (三唑类抗真菌药作用靶点)?

  1. Inhibition of squalene epoxidase in squalene pathway
  2. Inhibition of cytochrome P450-dependent Lanosterol 14α-demethylase (CYP51 / 羊毛甾醇14α-去甲基酶) Correct answer.
  3. Inhibition of β-(1,3)-D-glucan synthase in cell wall assembly
  4. Inhibition of fungal DNA topoisomerase II

Explanation

Azole antifungals (triazoles like fluconazole, voriconazole, itraconazole) selectively inhibit fungal cytochrome P450-dependent Lanosterol 14α-demethylase (encoded by ERG11 / CYP51). This blocks the conversion of lanosterol to ergosterol, leading to ergosterol depletion and accumulation of toxic 14α-methylated sterols that disrupt fungal membrane permeability and inhibit fungal growth.

Question 3Pharmacokinetics, therapeutic monitoring and explicit calculation models

Which of the following metabolic transformations represents a Phase II conjugation reaction (第II相结合反应) in human drug metabolism?

  1. Aromatic hydroxylation catalyzed by Cytochrome P450 3A4 (CYP3A4芳环羟基化)
  2. Ester hydrolysis catalyzed by serum carboxylesterase (酯酶水解)
  3. Sulfoxidation catalyzed by flavin-containing monooxygenase (黄素单加氧酶硫氧化)
  4. Glucuronidation catalyzed by UDP-glucuronosyltransferase (UDP-葡萄糖醛酸转移酶结合反应) Correct answer.

Explanation

Drug metabolism is divided into Phase I functionalization reactions (oxidation, reduction, hydrolysis that introduce or unmask polar functional groups like -OH, -COOH, -NH2, -SH) and Phase II conjugation reactions (结合反应), where endogenous hydrophilic molecules such as glucuronic acid, sulfate, glutathione, glycine, or acetate are covalently attached to make metabolites highly water-soluble for renal or biliary excretion.

Question 4Pharmacokinetics, therapeutic monitoring and explicit calculation models

In pharmaceutical chiral chemistry, why does Esomeprazole (艾司奥美拉唑 / S-奥美拉唑) demonstrate superior systemic bioavailability and less inter-individual pharmacokinetic variability compared to the racemic mixture Omeprazole?

  1. The (S)-enantiomer undergoes significantly lower first-pass hepatic metabolism by CYP2C19 than the (R)-enantiomer, achieving higher AUC (S-异构体受CYP2C19代谢清除率显著低于R-异构体) Correct answer.
  2. The (S)-enantiomer binds irreversibly to gastric H+/K+-ATPase whereas the (R)-enantiomer is completely inactive
  3. The (S)-enantiomer is absorbed via active peptide transporters whereas the (R)-enantiomer is not absorbed
  4. The (R)-enantiomer causes competitive inhibition of the proton pump whereas the (S)-enantiomer acts as an allosteric opener

Explanation

Esomeprazole is the S-enantiomer and has relevant metabolic differences from the racemic comparison, which can alter systemic exposure under the specified conditions. Genetics, formulation, dose and interacting medicines also affect results. A stereochemical comparison does not guarantee identical improved exposure or therapeutic benefit in every person.

Question 5Dosage forms, formulation behavior and responsible preparation

Which oral solid dosage form utilizes a semipermeable membrane coating with laser-drilled delivery orifices to achieve constant, zero-order drug release driven by internal hydrostatic osmotic pressure (渗透泵控释片)?

  1. Enteric-Coated Delayed-Release Tablet (肠溶片)
  2. Osmotic Pump Controlled-Release Tablet (渗透泵控释制剂) Correct answer.
  3. Effervescent Disintegrating Tablet (泡腾片)
  4. Erodible Matrix Sustained-Release Tablet (溶蚀性骨架片)

Explanation

Osmotic pump tablets (渗透泵制剂, e.g., Nifedipine GITS / 硝苯地平控释片) consist of an active drug core surrounded by a rigid semipermeable membrane with a laser-drilled microscopic orifice. Water from gastrointestinal fluids permeates into the core, dissolving osmotic agents and generating hydrostatic pressure that pumps drug solution out through the orifice at a steady, zero-order release rate independent of gastrointestinal pH and motility.

Question 6Dosage forms, formulation behavior and responsible preparation

In semi-solid formulation science, what type of ointment base is exemplified by hydrophilic petrolatum and anhydrous lanolin (羊毛脂), capable of absorbing substantial amounts of water while remaining non-washable with water?

  1. Water-Soluble Polyethylene Glycol Base (水溶性PEG基质)
  2. Oil-in-Water Emulsion Base (O/W型乳剂基质 / 水包油型)
  3. Oleaginous Hydrocarbon Base (单纯烃类油脂性基质)
  4. Absorption / Emulsifiable Hydrocarbon Base (吸收性软膏基质) Correct answer.

Explanation

Absorption ointment bases (吸收性基质, e.g., anhydrous lanolin / 羊毛脂, hydrophilic petrolatum) consist of hydrocarbon or lipid bases combined with W/O emulsifiers (such as sterols or cholesterol). They can absorb significant quantities of aqueous solutions to form W/O emulsions, providing occlusive emollient protection.

Question 7Pharmaceutical analysis, identity, stability and quality evidence

In pharmaceutical analytical testing under the Chinese Pharmacopoeia (《中国药典》), which quantitative principle states that absorbance (A) is directly proportional to both absorption path length (b) and solution concentration (c) in UV-Vis spectrophotometry?

  1. Nernst Distribution Law (能斯特分配定律)
  2. Bragg's Law of X-ray Diffraction (布拉格定律)
  3. Lambert-Beer Law (朗伯-比尔定律: A = εbc) Correct answer.
  4. Fick's First Law of Diffusion (菲克第一扩散定律)

Explanation

The Lambert-Beer Law (朗伯-比尔定律) is the fundamental physical law governing UV-Vis absorption spectroscopy: A = E1%1cm * c * L (or A = εbc), where A is absorbance, ε is molar absorptivity, b is the optical path length in cm, and c is molar concentration. It forms the quantitative basis for spectrophotometric drug assay content determination.

Question 8Pharmaceutical analysis, identity, stability and quality evidence

In pharmaceutical manufacturing and hospital preparation of sterile injectables, which method is widely utilized for bacterial endotoxin testing (细菌内毒素检查) based on the gelation of amoebocyte lysate from the horseshoe crab?

  1. Rabbit Pyrogen Test (家兔发热试验法)
  2. Membrane filtration bioburden sterility test (薄膜过滤法无菌检查)
  3. Limulus Amebocyte Lysate assay (TAL/LAL assay / 鲎试剂法) Correct answer.
  4. High-Performance Liquid Chromatography (高效液相色谱法)

Explanation

The Limulus Amebocyte Lysate (LAL/TAL / 鲎试剂) test is the primary, highly sensitive in vitro assay specified in the Chinese Pharmacopoeia for detecting bacterial endotoxins (LPS from Gram-negative bacteria). Endotoxins activate clotting enzyme cascades in the amebocyte lysate from Tachypleus tridentatus or Limulus polyphemus, producing a firm gel clot or optical turbidity.

Question 9Medical biology, diagnostic evidence and sample interpretation

In human cellular physiology, which transport mechanism is responsible for moving Na+ out of the cell and K+ into the cell against their respective concentration gradients, consuming ATP in the process (主动转运)?

  1. Sodium-potassium adenosine triphosphatase pump (Na+/K+-ATPase 钠钾泵) Correct answer.
  2. Voltage-gated sodium channel facilitated diffusion (电压门控钠通道易化扩散)
  3. Simple lipid bilayer passive diffusion (简单扩散)
  4. Potassium leak channel passive efflux (钾漏通道被动外流)

Explanation

Primary active transport (原发性主动转运) moves ions across the plasma membrane against electrochemical gradients using energy directly derived from ATP hydrolysis. The Na+/K+-ATPase pump expels 3 Na+ ions from the intracellular compartment in exchange for importing 2 K+ ions per ATP molecule hydrolyzed, maintaining resting membrane potential and cell volume.

Question 10Medical biology, diagnostic evidence and sample interpretation

During the action potential of ventricular cardiac working myocytes (心室肌动作电位), which ionic current is primarily responsible for the characteristic Phase 2 plateau (2期平台期)?

  1. Fast inward Na+ current via Nav1.5 channels (INa)
  2. Inward Ca2+ current via L-type calcium channels (ICa-L) balanced by delayed rectifier outward K+ current (IK) Correct answer.
  3. Transient outward K+ current (Ito)
  4. Inward rectifier K+ current maintaining resting potential (IK1)

Explanation

Phase 2 (plateau phase / 平台期) of the ventricular cardiac action potential is characterized by a balance between the slow inward flow of Ca2+ through L-type calcium channels (ICa-L) and the outward flow of K+ through delayed rectifier potassium channels (IK). This prolonged plateau prolongs the effective refractory period (ERP), preventing tetanic cardiac contraction.

Question 11Clinical pharmacy review, counseling and safe escalation

A patient with acute coronary syndrome undergoes percutaneous coronary intervention (PCI) with drug-eluting stent placement. Genetic testing reveals the patient is a CYP2C19*2/*2 homozygous loss-of-function poor metabolizer (慢代谢型). Why is Clopidogrel (氯吡格雷) ineffective in this patient, and which P2Y12 inhibitor is guideline-recommended instead?

  1. Clopidogrel is toxic to CYP2C19 poor metabolizers causing acute hemolysis; Warfarin should be substituted
  2. Clopidogrel is an inactive prodrug requiring CYP2C19 bioactivation into its active thiol metabolite; Ticagrelor (替格瑞洛) is direct-acting and independent of CYP2C19 bioactivation (氯吡格雷需CYP2C19活化，应换用直接作用的替格瑞洛) Correct answer.
  3. Clopidogrel irreversibly blocks COX-1; Aspirin monotherapy should be used instead
  4. Clopidogrel is cleared too rapidly in CYP2C19*2 carriers; doubling the clopidogrel dose is the sole guideline recommendation

Explanation

Clopidogrel is a thienopyridine prodrug that requires a two-step hepatic bioactivation process, in which CYP2C19 plays the predominant role in forming the active thiol metabolite that irreversibly blocks the platelet P2Y12 ADP receptor. CYP2C19*2 and *3 alleles encode non-functional enzymes; homozygous poor metabolizers (*2/*2) cannot form sufficient active drug, leading to high on-treatment platelet reactivity and stent thrombosis. Ticagrelor (替格瑞洛) is a cyclopentyltriazolopyrimidine that is active without metabolic bioactivation, making it the preferred first-line agent.

Question 12Clinical pharmacy review, counseling and safe escalation

Aminoglycoside antibiotics (e.g., Gentamicin, Amikacin / 庆大霉素、阿米卡星) exhibit concentration-dependent killing and a significant Post-Antibiotic Effect (PAE / 抗生素后效应). What are their two principal organ toxicities that mandate clinical therapeutic drug monitoring?

  1. Ototoxicity (vestibulocochlear damage) and Nephrotoxicity (acute tubular necrosis) (耳毒性与肾毒性) Correct answer.
  2. Hepatotoxicity and Aplastic anemia
  3. Pulmonary fibrosis and Peripheral neuropathy
  4. Retinal macular degeneration and Tendon rupture

Explanation

Aminoglycosides selectively accumulate in the perilymph/endolymph of the inner ear and the proximal tubular epithelial cells of the renal cortex. They cause Ototoxicity (耳毒性 - permanent cochlear sensory hair cell damage and vestibular dysfunction causing hearing loss, tinnitus, and ataxia) and Nephrotoxicity (肾毒性 - typically non-oliguric acute tubular necrosis with elevated serum creatinine). Both toxicities correlate with elevated trough concentrations and prolonged treatment duration.

Question 13Dispensing systems, medication reconciliation and error prevention

In patient medication safety management, what operational strategy is required for Look-Alike Sound-Alike (LASA / 听似看似易混淆药品) and High-Alert Medications (高警示药品)?

  1. Physical segregation, conspicuous high-alert warning labels, tall-man lettering on electronic interfaces, and independent double-check verification prior to dispensing (分开放置、警示标识、高警示双人复核) Correct answer.
  2. Alphabetical co-shelving to minimize dispensary retrieval transit time
  3. Permitting verbal telephone orders without written read-back confirmation
  4. Dispensing without independent secondary verification in high-volume rush periods

Explanation

Patient safety standards mandated by the NHC and the Institute for Safe Medication Practices (ISMP) require that LASA drugs (e.g., vincristine vs vinblastine, ephedrine vs epinephrine) and high-alert medications (e.g., concentrated potassium chloride, 10% NaCl, insulin, heparin) must be stored in physically segregated bins with bold colored warning labels (警示标识), utilize tall-man lettering, and undergo mandatory independent double-checking (双人核对) before dispensing.

Question 14Dispensing systems, medication reconciliation and error prevention

A clinical pharmacist auditing an inpatient prescription notices an order for '10% Potassium Chloride Injection 10 mL via Direct Intravenous Bolus (静脉推注)'. What immediate intervention is required and why?

  1. Approve the prescription provided it is administered over 2 minutes
  2. Change the route to subcutaneous injection without physician consultation
  3. Intervene immediately to intercept the order: Direct intravenous push of concentrated potassium chloride causes acute cardiac arrest and is strictly prohibited; it must be diluted into intravenous infusions to a final concentration not exceeding 0.3% w/v (严禁直接静脉推注高浓度氯化钾，可致心脏骤停，输注浓度严禁超过0.3%) Correct answer.
  4. Approve the order if the patient has documented hypokalemia

Explanation

Concentrated Potassium Chloride (10% KCl) is a Class A High-Alert Medication (高警示药品). Direct intravenous push (静脉推注/静脉注射) causes sudden, massive hyperkalemia in the coronary circulation, depolarizing the cardiac resting membrane potential, abolishing cardiac automaticity and conduction, and inducing immediate fatal diastolic cardiac arrest (心脏骤停). Potassium chloride MUST be diluted in IV fluids (e.g., normal saline or 5% glucose) to a final concentration strictly ≤0.3% w/v (3 g KCl per 1000 mL fluid) and administered via controlled infusion at a rate not exceeding 20 mmol/h (1.5 g/h).

Question 15Evidence appraisal, calculations and pharmacy resource decisions

In hospital pharmacy inventory management, what is the Economic Order Quantity (EOQ / Formule de Wilson) used to determine, and how does the ABC analysis classify pharmaceutical inventory?

  1. EOQ determines the optimal order size that minimizes the sum of ordering costs and inventory holding/carrying costs; ABC analysis stratifies stock by annual consumption value (Class A = ~10–20% of items accounting for ~70–80% of total budget) Correct answer.
  2. EOQ calculates drug expiration dates; ABC analysis classifies drugs alphabetically by brand name
  3. EOQ determines the lethal dose 50 of toxic waste; ABC analysis sorts medicines by tablet shape
  4. EOQ calculates nurse salary deductions; ABC analysis sorts products by package weight

Explanation

The Wilson formula calculates the Economic Order Quantity: EOQ = sqrt((2 × Annual Demand × Ordering Cost) / Holding Cost per unit). ABC analysis applies Pareto's 80/20 principle to hospital pharmacy management: Class A items (high financial value, ~70–80% of expenditure, ~10–20% of line items) receive rigorous daily inventory control; Class B items (intermediate, ~15–20% value); Class C items (low financial value, ~5–10% value, ~60–70% of line items).

Question 16Pharmacy qualification roles, scientific references and local duties

In clinical pharmacy and patient safety, what is Medication Reconciliation (Conciliation des traitements médicamenteux / Medication reconciliation), and at what clinical transition points should it be systematically performed?

  1. A formal multidisciplinary process where the clinical pharmacist compiles the exhaustive Best Possible Medication History (BPMH) and compares it with active hospital prescriptions to detect and intercept unintended discrepancies, omissions, and duplications at hospital admission, intra-hospital transfer, and discharge Correct answer.
  2. A billing audit performed by hospital accounting at patient discharge
  3. Verification that the brand names match the hospital formulary exclusively
  4. A laboratory test measuring all drug concentrations in blood simultaneously

Explanation

Medication reconciliation (conciliation médicamenteuse) is a formalized patient safety process led by clinical pharmacists. By interviewing the patient, family, community pharmacist, and attending physician, the pharmacist establishes the Best Possible Medication History (BPMH / Bilan Médicamenteux Optimisé) and cross-references it with current hospital orders, identifying and correcting unintended discrepancies (omitted chronic therapies, dosing errors, duplicates) at admission, ward transfer, and discharge.

Question 17Pharmacodynamic targets, class effects and therapeutic limits

In the medicinal chemistry of beta-lactam antibiotics, what structural feature makes the penicillin bicyclic core (penam ring / 青霉烷环) chemically unstable and prone to acid-catalyzed degradation?

  1. The presence of an aromatic phenyl ring at C-6
  2. The sulfur atom in the thiazolidine ring existing in the sulfoxide oxidation state
  3. High steric angle strain across the fused 4-membered β-lactam and 5-membered thiazolidine ring preventing resonance stabilization (四元环与五元环稠合的高环张力与非共面性) Correct answer.
  4. A completely planar aromatic heterocyclic core system

Explanation

Penicillins possess a 6-aminopenicillanic acid (6-APA) skeleton consisting of a fused 4-membered β-lactam ring and a 5-membered thiazolidine ring. Because of the sharp angles between the fused rings, the nitrogen atom is unable to participate in normal planar resonance with the carbonyl group, resulting in high ring strain, high carbonyl electrophilicity, and extreme vulnerability to nucleophilic attack, acid hydrolysis, and beta-lactamase cleavage.

Question 18Pharmacodynamic targets, class effects and therapeutic limits

What is the fundamental structural reason why sulfonamide antimicrobials (磺胺类药物) competitively inhibit dihydropteroate synthase in bacteria?

  1. Sulfonamides covalently alkylate bacterial 50S ribosomal RNA
  2. Sulfonamides chelate magnesium ions required for bacterial RNA polymerase
  3. Sulfonamides contain a beta-lactam carbonyl that mimics D-Ala-D-Ala
  4. Sulfonamides are bioisosteres that closely mimic the structure, size, and charge distribution of p-aminobenzoic acid (对氨基苯甲酸 PABA 类似物) Correct answer.

Explanation

Sulfonamides (such as sulfamethoxazole) are classic bioisosteres (生物电子等排体) of para-aminobenzoic acid (PABA / 对氨基苯甲酸). The benzene ring, primary aromatic amino group (-NH2), and sulfonyl group closely mimic the molecular dimensions, geometry, and charge distribution of PABA, allowing them to competitively occupy the active site of bacterial dihydropteroate synthase (二氢叶酸合成酶).

Question 19Pharmacodynamic targets, class effects and therapeutic limits

In the medicinal chemistry of ACE inhibitors (ACEI), which functional group in Captopril (卡托普利) is responsible for its zinc-binding efficacy but also directly implicated in adverse effects such as skin rashes and taste disturbances (dysgeusia)?

  1. Sulfhydryl group (-SH / 巯基) Correct answer.
  2. Carboxyl group (-COOH / 羧基)
  3. Phosphonate group (-PO3H2 / 膦酸基)
  4. Ester prodrug ethyl group (-COOCH2CH3 / 乙酯基)

Explanation

Captopril was the first orally active ACE inhibitor. It utilizes a sulfhydryl (-SH / 巯基) group to chelate the catalytic Zn2+ ion in the active site of Angiotensin Converting Enzyme. However, the reactive thiol moiety forms disulfides with endogenous proteins, resulting in immunogenic reactions including skin rashes, pruritus, and loss or alteration of taste (dysgeusia / 味觉障碍). Subsequent ACE inhibitors (e.g., enalapril, lisinopril) replaced the thiol group with carboxyl or phosphonate groups.

Question 20Pharmacodynamic targets, class effects and therapeutic limits

Which essential pharmacophore structure is shared by all HMG-CoA reductase inhibitors (statins / 他汀类药物) that mimics the natural tetrahedral intermediate of HMG-CoA?

  1. A dihydropyridine ring with C-4 aryl substitution
  2. A 3,5-dihydroxyheptanoic acid moiety (or its closed delta-lactone ring) (3,5-二羟基庚酸链或其δ-内酯环) Correct answer.
  3. A thiazolidinedione ring substituted with an ethoxy linker
  4. A 1,4-benzodiazepine core

Explanation

All statins share a critical 3,5-dihydroxyheptanoic acid moiety (or a delta-lactone prodrug that hydrolyzes in vivo to this open-ring acid, as in lovastatin and simvastatin). This dihydroxy acid chain structurally mimics the natural substrate 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) and its tetrahedral transition state, competitively blocking HMG-CoA reductase.

Question 21Pharmacodynamic targets, class effects and therapeutic limits

In fluoroquinolone medicinal chemistry (喹诺酮类药物构效关系), which pair of functional groups at positions C-3 and C-4 is essential for antibacterial activity by chelating magnesium ions in the DNA gyrase-DNA complex, but also causes chelation with divalent/trivalent metal cations (Ca2+, Mg2+, Fe3+, Al3+) in food or antacids?

  1. C-6 Fluorine atom and C-7 Piperazine ring (6位氟原子与7位哌嗪环)
  2. C-1 Cyclopropyl group and C-8 Methoxy group (1位环丙基与8位甲氧基)
  3. C-3 Carboxylic acid group and C-4 Carbonyl group (3位羧基与4位酮羰基) Correct answer.
  4. C-2 Methyl group and C-5 Amino group (2位甲基与5位氨基)

Explanation

The 4-quinolone core requires a C-3 carboxylic acid (-COOH) and an adjacent C-4 carbonyl (=O) group for antibacterial efficacy. Together, these two oxygen-containing groups form a bidentate chelate with Mg2+ ions coordinating DNA gyrase/topoisomerase IV with bacterial DNA. However, this same chelation site readily binds Ca2+, Mg2+, Al3+, and Fe3+ in antacids, milk, and iron supplements, forming insoluble precipitates that drastically reduce oral bioavailability.

Question 22Pharmacodynamic targets, class effects and therapeutic limits

Which lipid-derived inflammatory mediator is produced via the cyclooxygenase (COX) pathway and directly induces local vasodilation, increases microvascular permeability, and sensitizes peripheral nociceptors to pain (致痛与致炎介质)?

  1. Leukotriene B4 (白三烯 B4 / LTB4)
  2. Thromboxane A2 (血栓素 A2 / TXA2)
  3. Lipoxin A4 (脂氧素 A4 / LXA4)
  4. Prostaglandin E2 (前列腺素 E2 / PGE2) Correct answer.

Explanation

Prostaglandin E2 (PGE2 / 前列腺素E2) is synthesized from arachidonic acid by cyclooxygenase-1 and -2 (COX-1/COX-2) and prostaglandin E synthase. PGE2 acts on EP receptors to mediate arterial vasodilation, enhance vascular permeability, sensitize primary afferent C-fiber nociceptors to bradykinin and histamine (producing hyperalgesia), and elevate the hypothalamic thermoregulatory set point to produce fever.

Question 23Pharmacodynamic targets, class effects and therapeutic limits

In autonomic pharmacology, what is the primary clinical mechanism of Atropine (阿托品) when administered during emergency resuscitation for severe organophosphate pesticide poisoning (有机磷农药中毒)?

  1. Competitive antagonism of postganglionic muscarinic acetylcholine receptors (M受体竞争性拮抗剂) Correct answer.
  2. Direct chemical reactivation of phosphorylated acetylcholinesterase enzymes
  3. Selective blockade of nicotinic acetylcholine receptors at the neuromuscular junction
  4. Stimulation of presynaptic alpha-2 adrenergic receptors to inhibit acetylcholine release

Explanation

Organophosphate poisoning irreversibly inhibits acetylcholinesterase (AChE), causing massive systemic accumulation of acetylcholine (ACh). Atropine is a competitive antagonist of muscarinic (M) acetylcholine receptors. It rapidly relieves lethal muscarinic symptoms ('atropinization' / 阿托品化: relieving bronchospasm, drying secretions, resolving bradycardia and miosis). Pralidoxime (解磷定), by contrast, is the AChE enzyme reactivator.

Question 24Pharmacodynamic targets, class effects and therapeutic limits

Which neuromuscular blocking agent acts as a depolarizing muscle relaxant (去极化肌松药), characteristically causes transient initial muscle fasciculations, and carries risks of triggering malignant hyperthermia and severe hyperkalemia in burn/trauma patients?

  1. Cisatracurium (顺阿曲库铵)
  2. Succinylcholine / Suxamethonium (琥珀胆碱) Correct answer.
  3. Rocuronium (罗库溴铵)
  4. Vecuronium (维库溴铵)

Explanation

Succinylcholine (琥珀胆碱 / 司可林) is the prototype depolarizing neuromuscular blocker. It binds to nicotinic acetylcholine receptors (Nm) at the motor endplate, generating persistent Phase I depolarization accompanied by initial muscle fasciculations (肌束震颤). It is metabolized by plasma pseudocholinesterase. It can trigger life-threatening hyperkalemia in denervated, burn, or massive trauma patients, and can precipitate malignant hyperthermia (恶性高热) when combined with inhaled volatile anesthetics.

Question 25Pharmacodynamic targets, class effects and therapeutic limits

Which listed receptor mechanism explains why nonselective propranolol can worsen bronchoconstriction in a susceptible patient, rather than asserting one identical contraindication rule for every COPD presentation?

  1. Direct stimulation of alpha-1 receptors causing pulmonary arterial vasoconstriction
  2. Inhibition of mast cell degranulation triggering histamine release
  3. Blockade of bronchial smooth muscle beta-2 receptors leads to unopposed bronchoconstriction and fatal bronchospasm (阻断支气管β2受体诱发严重支气管痉挛) Correct answer.
  4. Activation of muscarinic M3 receptors in airway mucosal glands

Explanation

Blocking bronchial beta-2 signaling can oppose an important bronchodilator pathway and provoke or worsen bronchoconstriction in susceptible patients. The answer tests receptor physiology, not a universal prediction of fatality or permission to change a medicine without clinical assessment. Patient disease, indication and the actual product guidance matter.

Question 26Pharmacodynamic targets, class effects and therapeutic limits

What is the primary hemodynamic mechanism responsible for the common adverse effect of bilateral peripheral ankle edema (踝部水肿) associated with dihydropyridine calcium channel blockers such as Amlodipine and Nifedipine (二氢吡啶类CCB)?

  1. Direct renal tubular sodium and water retention via aldosterone activation
  2. Systemic reduction in serum albumin synthesis by the liver
  3. Severe acute left ventricular systolic pump failure
  4. Selective arteriolar precapillary vasodilation without matching postcapillary venular dilation, increasing intracapillary hydrostatic pressure and fluid extravasation (前毛细血管扩张导致毛细血管流体静压增高) Correct answer.

Explanation

Dihydropyridine CCBs (amlodipine, nifedipine, felodipine) are potent arterial vasodilators that selectively relax precapillary arterioles with minimal effect on postcapillary venules. This selective precapillary dilation elevates intracapillary hydrostatic pressure (毛细血管流体静压升高), forcing fluid out of the microvasculature into surrounding dependent tissues (ankle edema). Combining a CCB with an ACEI or ARB produces balanced postcapillary venular dilation, reducing this hydrostatic pressure and mitigating edema.

Question 27Pharmacodynamic targets, class effects and therapeutic limits

What biochemical mechanism explains why Angiotensin-Converting Enzyme Inhibitors (ACEI, e.g., Enalapril) frequently cause a persistent dry cough (刺激性干咳), whereas Angiotensin II Receptor Blockers (ARB, e.g., Losartan) rarely do?

  1. ACE is identical to Kininase II; ACE inhibition prevents the degradation of Bradykinin and Substance P in pulmonary airways (抑制缓激肽与P物质降解导致气道蓄积) Correct answer.
  2. ACE inhibitors directly stimulate bronchial histamine H1 receptors
  3. ARBs selectively stimulate pulmonary nitric oxide synthase to bronchodilate
  4. ACE inhibitors cause direct leukotriene B4 hypersecretion in alveolar macrophages

Explanation

Angiotensin-Converting Enzyme (ACE) is biochemically identical to Kininase II, the enzyme responsible for degrading bradykinin (缓激肽) and Substance P. When ACE is inhibited by drugs like enalapril or captopril, bradykinin, Substance P, and prostaglandins accumulate in lung bronchial tissues, stimulating local sensory C-fibers and provoking a chronic, intractable dry cough (5%–20% incidence). ARBs block the downstream AT1 receptor directly without inhibiting kininase II, leaving bradykinin levels normal.

Question 28Pharmacodynamic targets, class effects and therapeutic limits

At which nephron segment and molecular transport mechanism do Loop Diuretics such as Furosemide (呋塞米 / 速尿) act to produce their potent high-ceiling diuretic effect?

  1. Inhibition of the Na+/Cl- cotransporter in the early distal convoluted tubule
  2. Inhibition of the Na+/K+/2Cl- symporter in the thick ascending limb of Henle's loop (抑制髓袢升支粗段 Na+-K+-2Cl- 协同转运体) Correct answer.
  3. Competitive antagonism of mineralocorticoid aldosterone receptors in the collecting duct
  4. Inhibition of carbonic anhydrase in the proximal convoluted tubule

Explanation

Loop diuretics (furosemide, torsemide, bumetanide) reversibly bind to the chloride-binding site of the Na+/K+/2Cl- cotransporter (NKCC2) in the thick ascending limb of the loop of Henle (髓袢升支粗段). This abolishes the hypertonic medullary osmotic gradient, preventing water reabsorption from collecting ducts and causing profound natriuresis, chloruresis, kaliuresis, and calciuresis.

Question 29Pharmacodynamic targets, class effects and therapeutic limits

Which Class III antiarrhythmic agent blocks multiple cardiac ion channels (potassium, sodium, calcium, and beta-receptors), has an extremely long elimination half-life (30–60 days), and requires monitoring for pulmonary fibrosis, corneal microdeposits, and thyroid dysfunction (胺碘酮的不良反应)?

  1. Procainamide (普鲁卡因胺)
  2. Lidocaine (利多卡因)
  3. Amiodarone (胺碘酮) Correct answer.
  4. Propafenone (普罗帕酮)

Explanation

Amiodarone (胺碘酮) is a broad-spectrum Class III antiarrhythmic that prolongs action potential duration and effective refractory period by blocking IKr potassium channels, while also exhibiting Class I (Na+ block), Class II (anti-adrenergic), and Class IV (Ca2+ block) properties. Due to extensive tissue lipophilicity, its elimination half-life is 30–60 days. Chronic use requires monitoring for lethal pulmonary toxicity (肺纤维化), thyroid dysfunction (contains iodine atoms, causing hypo- or hyperthyroidism), corneal microdeposits (角膜色素沉着), hepatotoxicity, and skin discoloration.

Question 30Pharmacodynamic targets, class effects and therapeutic limits

Which oral direct anticoagulant is a Direct Thrombin (Factor IIa) Inhibitor prodrug (直接凝血酶抑制剂), and what specific humanized monoclonal antibody Fab fragment serves as its targeted rapid reversal antidote?

  1. Dabigatran etexilate, reversed specifically by Idarucizumab (达比加群酯，特异性拮抗剂为依达赛珠单抗) Correct answer.
  2. Rivaroxaban, reversed specifically by Protamine sulfate
  3. Apixaban, reversed specifically by Vitamin K1
  4. Edoxaban, reversed specifically by Fresh Frozen Plasma alone

Explanation

Dabigatran etexilate (达比加群酯) is an oral prodrug that is converted in plasma and liver to dabigatran, a direct, reversible, competitive inhibitor of free and clot-bound Thrombin (Factor IIa). Its specific, humanized monoclonal antibody Fab reversal agent is Idarucizumab (依达赛珠单抗 / Praxbind), which binds dabigatran with an affinity ~350 times higher than thrombin, neutralizing its anticoagulant effect within minutes.

Question 31Pharmacodynamic targets, class effects and therapeutic limits

Which lipid-lowering agent works by selectively binding to the Niemann-Pick C1-Like 1 (NPC1L1 / 尼曼-匹克C1类1) transporter protein on the brush border of intestinal enterocytes, thereby inhibiting the absorption of dietary and biliary cholesterol?

  1. Fenofibrate (非诺贝特)
  2. Colestyramine (考来烯胺)
  3. Ezetimibe (依折麦布) Correct answer.
  4. Evolocumab (依洛尤单抗)

Explanation

Ezetimibe (依折麦布) selectively localizes to the brush border of small intestinal enterocytes and specifically inhibits the NPC1L1 cholesterol transporter. This reduces intestinal absorption of dietary and biliary cholesterol by ~54%, decreasing hepatic cholesterol delivery, upregulating hepatic LDL receptors, and lowering plasma LDL-C by 15%–20% (often combined with statins for synergistic LDL reduction).

Question 32Pharmacodynamic targets, class effects and therapeutic limits

Why is the carbapenem antibiotic Imipenem (亚胺培南) formulated in a fixed 1:1 ratio with Cilastatin (西司他丁) for clinical intravenous infusion?

  1. Cilastatin acts as an ESBL beta-lactamase inhibitor
  2. Cilastatin increases the penetration of imipenem across the blood-brain barrier
  3. Cilastatin acts as an osmotic stabilizer preventing imipenem precipitation
  4. Cilastatin inhibits renal dehydropeptidase-I (DHP-1), preventing imipenem metabolic breakdown in renal proximal tubules and eliminating nephrotoxicity (抑制肾去氢肽酶-I，阻断亚胺培南水解) Correct answer.

Explanation

Imipenem is rapidly hydrolyzed and inactivated by dehydropeptidase-I (DHP-1 / 肾去氢肽酶-I) located on the brush border of renal proximal tubular cells, resulting in low urinary drug concentrations and nephrotoxic breakdown products. Cilastatin is a specific, reversible competitive inhibitor of DHP-1 with no intrinsic antibacterial activity. Co-administering cilastatin 1:1 prevents imipenem degradation, ensures high active urinary drug levels, and prevents proximal tubular toxicity. Newer carbapenems (meropenem, biapenem) are chemically stable against DHP-1 and do not require cilastatin.

Question 33Pharmacodynamic targets, class effects and therapeutic limits

Why does Erythromycin frequently provoke abdominal cramping, nausea, and hyperperistalsis as a common gastrointestinal adverse effect?

  1. Direct osmotic drawing of water into the colon lumen
  2. Selective blockade of intestinal VIP (vasoactive intestinal peptide) receptors
  3. Erythromycin and its acid degradation hemiketal products act as direct agonists on gastrointestinal Motilin receptors (激动胃肠道胃动素受体) Correct answer.
  4. Immune-mediated destruction of parietal cells

Explanation

Macrolides (especially 14-membered rings like erythromycin) structurally mimic the endogenous peptide hormone motilin. In the acidic stomach, erythromycin forms anhydrohemiketal and spiroketal degradation intermediates that act as potent agonists at motilin receptors on gastrointestinal smooth muscle, triggering strong phase-III migrating motor complexes (MMCs), gastric contractions, and gastrointestinal cramping.

Question 34Pharmacodynamic targets, class effects and therapeutic limits

Why is the lipopeptide antibiotic Daptomycin (达托霉素) ineffective and contraindicated in the clinical treatment of Community-Acquired or Hospital-Acquired bacterial pneumonia?

  1. Daptomycin cannot penetrate through Gram-positive bacterial cell walls
  2. Daptomycin is degraded by pulmonary alveolar carbonic anhydrase
  3. Daptomycin causes immediate precipitation with pulmonary capillary hemoglobin
  4. Daptomycin is bound and irreversibly inactivated by Pulmonary Surfactant in alveolar fluid (被肺泡表面活性物质结合灭活) Correct answer.

Explanation

Daptomycin (达托霉素) is a cyclic lipopeptide bactericidal agent with potent activity against MRSA and VRE in bloodstream and skin/soft tissue infections. However, in the lungs, daptomycin binds avidly to pulmonary surfactant (specifically dipalmitoylphosphatidylcholine), which inserts into its lipid tail and completely neutralizes its antibacterial activity. Therefore, daptomycin must NEVER be used to treat pneumonia.

Question 35Pharmacodynamic targets, class effects and therapeutic limits

Which intravenous antifungal agent is a polyene macrolide that binds to fungal membrane ergosterol to form aqueous pores, but frequently induces acute infusion-related shivering/fevers ('shake and bake') and cumulative nephrotoxicity?

  1. Amphotericin B deoxycholate (两性霉素B脱氧胆酸盐) Correct answer.
  2. Fluconazole (氟康唑)
  3. Caspofungin (卡泊芬净)
  4. Flucytosine (氟胞嘧啶)

Explanation

Amphotericin B (两性霉素B) is a polyene antifungal that selectively binds to ergosterol in fungal cell membranes, creating transmembrane cylindrical pores that leak essential ions (K+, Mg2+) and cause fungal cell lysis. Because it weakly binds mammalian cholesterol, it carries high host toxicity: acute infusion reactions (rigors, chills, fever mediated by TNF-alpha/IL-1) and direct renal vasoconstriction / tubular necrosis leading to hypokalemia, hypomagnesemia, and renal failure.

Question 36Pharmacodynamic targets, class effects and therapeutic limits

What is the molecular mechanism of Oseltamivir (奥司他韦) in the treatment and prophylaxis of Influenza A and B viral infections?

  1. Blockade of the viral M2 ion channel preventing endosomal uncoating
  2. Selective competitive inhibition of viral Neuraminidase, preventing the release and dissemination of newly formed progeny virions from infected host cells (选择性抑制流感病毒神经氨酸酶，阻止子代病毒释放) Correct answer.
  3. Inhibition of viral cap-dependent endonuclease (PA subunit)
  4. Inhibition of host cell RNA polymerase II

Explanation

Oseltamivir phosphate is an oral prodrug converted by hepatic esterases to oseltamivir carboxylate, a potent competitive inhibitor of influenza A and B viral Neuraminidase (NA / 神经氨酸酶). Neuraminidase cleaves terminal sialic acid residues on host cell receptors; inhibiting NA causes newly replicated virions to remain clumped to the host cell surface and to each other, halting viral transmission within the respiratory tract.

Question 37Pharmacodynamic targets, class effects and therapeutic limits

Which listed signaling pathway and metabolic effects are associated with metformin, without claiming that one pathway completely explains every clinical action?

  1. Stimulation of pancreatic beta-cell SUR1 receptors; carries risk of profound hypoglycemic coma
  2. Selective inhibition of intestinal alpha-glucosidase; carries risk of paralytic ileus
  3. Activation of AMP-activated protein kinase (AMPK) to suppress hepatic gluconeogenesis and improve peripheral insulin sensitivity; carries risk of Lactic Acidosis (激活AMPK抑制肝糖原异生；主要风险为乳酸性酸中毒) Correct answer.
  4. Direct stimulation of renal tubular glucose reabsorption; carries risk of hyperosmolar ketoacidosis

Explanation

AMPK-related signaling is associated with metformin effects, but the drug has complex actions and not every effect is mediated exclusively through that pathway. Interpretation of benefit and rare serious harms requires the actual patient and current product information. The mechanism answer does not select a universal prescription or remove renal and other assessment needs.

Question 38Pharmacodynamic targets, class effects and therapeutic limits

Which class of oral antidiabetic agents (e.g., Dapagliflozin, Empagliflozin / 达格列净、恩格列净) acts by inhibiting sodium-glucose cotransporter-2 in the renal proximal tubule, promoting urinary glucose excretion while conferring proven cardiovascular and renal protective benefits?

  1. DPP-4 Inhibitors / Gliptins (二肽基肽酶-4抑制剂 / 列汀类)
  2. Thiazolidinediones / Glitazones (噻唑烷二酮类 / 列酮类)
  3. GLP-1 Receptor Agonists (GLP-1受体激动剂)
  4. SGLT2 Inhibitors / Gliflozins (钠-葡萄糖协同转运蛋白2抑制剂 / 列净类) Correct answer.

Explanation

SGLT2 inhibitors (列净类, e.g., dapagliflozin, empagliflozin) block sodium-glucose cotransporter 2 in the S1 segment of the renal proximal convoluted tubule. This prevents ~90% of renal glucose reabsorption, inducing glucosuria, mild osmotic diuresis, blood pressure reduction, weight loss, and intraglomerular pressure reduction. Clinical trials demonstrate robust reductions in heart failure hospitalizations and CKD progression.

Question 39Pharmacodynamic targets, class effects and therapeutic limits

How do GLP-1 Receptor Agonists (GLP-1 RA, e.g., Semaglutide, Dulaglutide / 司美格鲁肽、度拉糖肽) lower postprandial glycemia while minimizing intrinsic hypoglycemia risk?

  1. Glucose-dependent stimulation of insulin secretion, suppression of glucagon secretion, slowing of gastric emptying, and centrally mediated appetite suppression (葡萄糖浓度依赖性促进胰岛素分泌与抑制胰高血糖素分泌) Correct answer.
  2. Constitutive, continuous insulin release regardless of ambient blood glucose concentrations
  3. Direct degradation of ingested carbohydrates in the duodenal lumen
  4. Blockade of hepatic insulin receptors to prevent peripheral down-regulation

Explanation

GLP-1 receptor agonists (GLP-1 RA / 胰高血糖素样肽-1受体激动剂) activate GLP-1 receptors in a glucose-dependent manner (血糖浓度依赖性): when blood glucose is elevated, they stimulate beta-cell insulin secretion and suppress alpha-cell glucagon secretion. When glucose falls to normal levels, insulin stimulation ceases, resulting in minimal risk of monotherapy hypoglycemia. They also slow gastric emptying (延缓胃排空) and promote hypothalamic satiety.

Question 40Pharmacodynamic targets, class effects and therapeutic limits

What is the primary pharmacological rationale for using a Selective Cyclooxygenase-2 Inhibitor (such as Celecoxib / 塞来昔布) over a non-selective NSAID (such as Indomethacin or Ibuprofen)?

  1. Selective COX-2 inhibition preserves mucosal-protective gastric PGE2/PGI2 synthesized by constitutive COX-1, significantly reducing gastrointestinal ulcer and bleeding risks (保留COX-1胃黏膜保护作用，降低消化道溃疡出血风险) Correct answer.
  2. Selective COX-2 inhibitors eliminate all risks of ischemic cardiovascular thrombotic events
  3. Selective COX-2 inhibitors do not undergo hepatic metabolism
  4. Selective COX-2 inhibitors possess zero renal adverse effects

Explanation

Selective COX-2 inhibition can reduce some gastrointestinal effects relative to relevant nonselective comparators, but it does not eliminate gastrointestinal, cardiovascular or renal harm. Drug, exposure and patient factors influence the balance. The comparison supplies a pharmacological concept rather than one preferred treatment for every person.

Question 41Pharmacodynamic targets, class effects and therapeutic limits

Which targeted monoclonal antibody binds to the extracellular domain IV of the Human Epidermal Growth Factor Receptor 2 (HER2 / ErbB2) in HER2-positive breast cancer, requiring routine baseline and serial echocardiographic monitoring for Cardiotoxicity (left ventricular ejection fraction reduction)?

  1. Rituximab (利妥昔单抗)
  2. Trastuzumab (曲妥珠单抗 / 赫赛汀) Correct answer.
  3. Bevacizumab (贝伐珠单抗)
  4. Cetuximab (西妥昔单抗)

Explanation

Trastuzumab (曲妥珠单抗 / 赫赛汀) is a recombinant humanized IgG1 monoclonal antibody targeting HER2. It inhibits downstream MAPK and PI3K/Akt signaling and mediates antibody-dependent cellular cytotoxicity (ADCC). HER2 signaling is also essential for cardiomyocyte survival under oxidative stress; trastuzumab therapy can cause reversible, non-dose-dependent cardiotoxicity manifesting as asymptomatic LVEF declines or congestive heart failure, necessitating serial echocardiograms (UCG).

Question 42Pharmacokinetics, therapeutic monitoring and explicit calculation models

In clinical pharmacokinetics, what is indicated when a drug's Apparent Volume of Distribution (Vd / 表观分布容积) significantly exceeds total body water (e.g., Vd > 5 L/kg for Digoxin or Chloroquine)?

  1. The drug is completely restricted to the intravascular vascular space
  2. The drug has failed to cross the gastrointestinal mucosal barrier
  3. The drug is highly lipophilic or extensively bound to peripheral extravascular tissues, with only a small fraction remaining in plasma (药物广泛分布结合于外周组织，血浆中游离药物浓度极低) Correct answer.
  4. The drug is completely eliminated by renal filtration within one minute

Explanation

Apparent Volume of Distribution is defined as Vd = Total Amount of Drug in Body / Plasma Drug Concentration (C0). Total body water is approximately 0.6 L/kg (42 L in a 70 kg adult). When Vd far exceeds physiological fluid volumes (e.g., Digoxin Vd ~7 L/kg, Chloroquine Vd ~200 L/kg), it reflects extensive tissue and intracellular protein binding, leaving very little drug in circulating plasma. Such drugs cannot be effectively removed by hemodialysis during acute overdose.

Question 43Pharmacokinetics, therapeutic monitoring and explicit calculation models

For a drug following first-order elimination kinetics administered via continuous intravenous infusion or regular repeated dosing, approximately how many elimination half-lives (t1/2) are required to reach Steady-State plasma concentration (Css / 稳态血药浓度)?

  1. 1 half-life (1个半衰期)
  2. 10 to 12 half-lives (10～12个半衰期)
  3. 24 hours regardless of half-life
  4. 4 to 5 half-lives (4～5个半衰期) Correct answer.

Explanation

In the stated first-order accumulation model, four half-lives give 93.75 percent and five give 96.875 percent of the limiting steady-state level. The model approaches that limit rather than reaching mathematical completeness at five half-lives. Actual patients and nonlinear kinetics can require different interpretation.

Question 44Pharmacokinetics, therapeutic monitoring and explicit calculation models

A clinical pharmacist calculates a target steady-state plasma concentration (Css) of 15 mg/L for an antibiotic. The patient's total clearance (CL) is determined to be 4.0 L/h, and the drug has 100% bioavailability (F = 1). What hourly continuous intravenous maintenance infusion rate (R0 / 维持给药速率) is required?

  1. 60 mg/h (R0 = Css * CL = 15 mg/L * 4.0 L/h = 60 mg/h) Correct answer.
  2. 15 mg/h
  3. 3.75 mg/h
  4. 240 mg/h

Explanation

The supplied model uses input rate = target concentration × clearance: fifteen mg/L multiplied by four L/h gives sixty mg/h. The units reduce to mass per time. This fictional calculation does not establish a real antibiotic target, suitable model or authorized patient infusion.

Question 45Pharmacokinetics, therapeutic monitoring and explicit calculation models

In the therapeutic drug monitoring of Digoxin (地高辛TDM), why must serum blood samples be drawn at least 6 to 8 hours post-oral dose, and what electrolyte abnormality most severely potentiates digitalis cardiac toxicity (洋地黄中毒)?

  1. Sampling after 1 hour captures peak elimination; Hypernatremia potentiates toxicity
  2. Sampling after 24 hours only; Hypercalcemia has zero effect on digitalis
  3. Sampling immediately post-dose; Hypocalcemia potentiates toxicity
  4. Sampling after 6–8 hours allows completion of the prolonged tissue distribution phase; Hypokalemia (低钾血症) most severely potentiates digitalis toxicity (6-8小时后组织分布平衡完成；低钾血症最易诱发洋地黄中毒) Correct answer.

Explanation

Digoxin follows a two-compartment kinetic model with a very slow distribution phase (6–8 hours) before reaching equilibrium between plasma and myocardial Na+/K+-ATPase. Sampling before 6–8 hours yields falsely elevated non-equilibrium plasma concentrations. Hypokalemia (低钾血症) reduces K+ competition at the Na+/K+-ATPase pump, dramatically enhancing digoxin binding and triggering fatal cardiac arrhythmias (PVCs, ventricular tachycardia, bidirectional VT, junctional tachycardia).

Question 46Pharmacokinetics, therapeutic monitoring and explicit calculation models

A bipolar disorder patient maintained on Lithium Carbonate (碳酸锂, therapeutic range 0.6–1.2 mmol/L) is prescribed Hydrochlorothiazide and Ibuprofen for hypertension and osteoarthritis. What serious pharmacokinetic interaction will occur?

  1. Thiazides and NSAIDs dramatically increase lithium renal clearance causing subtherapeutic relapse
  2. Direct chemical neutralization of lithium carbonate in the stomach
  3. Thiazide-induced sodium depletion and NSAID-mediated renal prostaglandin inhibition decrease lithium clearance, triggering toxic lithium accumulation (利尿剂与NSAID抑制锂排泄，导致严重锂中毒) Correct answer.
  4. Inhibition of hepatic CYP2D6 metabolism of lithium

Explanation

Lithium is handled by the kidneys identically to sodium: filtered at the glomerulus and reabsorbed (80%) in the proximal tubule. Thiazide diuretics cause distal sodium loss, triggering compensatory proximal tubular reabsorption of both Na+ and Lithium, reducing lithium clearance by 30%–50%. NSAIDs inhibit renal prostaglandin synthesis, reducing renal blood flow and GFR. Co-prescribing thiazides or NSAIDs with lithium rapidly precipitates life-threatening Lithium Toxicity (ataxia, coarse tremor, dysarthria, renal failure, seizures).

Question 47Pharmacokinetics, therapeutic monitoring and explicit calculation models

In clinical pharmacokinetics, what is the standard formula for estimating Creatinine Clearance (CrCl) in a 65-year-old female patient using the classic Cockcroft-Gault equation?

  1. CrCl (mL/min) = [(140 - Age) * Weight (kg) / (72 * Scr (mg/dL))] * 0.85 (女性需乘以校正系数0.85) Correct answer.
  2. CrCl (mL/min) = (140 - Age) / (Scr * 72)
  3. CrCl (mL/min) = [(140 - Age) * Weight (kg) / (72 * Scr (mg/dL))] * 1.25
  4. CrCl (mL/min) = Weight (kg) * 140 / (Age * Scr)

Explanation

The listed formula is the classical Cockcroft-Gault estimate with its historical sex coefficient and stated creatinine units. It is not a universally interchangeable standard for every drug, body size, population or renal estimate. Clinical use follows the actual validated method, current product guidance and patient context.

Question 48Pharmacokinetics, therapeutic monitoring and explicit calculation models

In patients with decompensated hepatic cirrhosis and portal hypertension (肝硬化失代偿期), why does oral administration of drugs with a High Hepatic Extraction Ratio (高肝脏消除率药物, e.g., Propranolol, Morphine) lead to dramatically elevated systemic bioavailability and severe overdose toxicity?

  1. Hepatic cirrhosis upregulates phase I CYP enzymes by 500%
  2. Extensive intrahepatic and extrahepatic portosystemic shunting bypasses hepatic first-pass metabolism, directly dumping intact drug into the systemic circulation (门-体静脉分流导致首过消除显著减少，生物利用度剧增) Correct answer.
  3. Cirrhotic ascites completely prevents intestinal absorption
  4. Plasma albumin levels rise dramatically in cirrhosis

Explanation

Drugs with a high intrinsic hepatic extraction ratio (ER > 0.7, such as propranolol, morphine, lidocaine, verapamil) normally undergo extensive hepatic first-pass metabolism (首过效应), with only a small percentage reaching systemic circulation. In cirrhosis, portosystemic shunting (门-体分流) allows mesenteric venous blood to bypass functional liver parenchyma entirely. Consequently, oral bioavailability can surge from 10%–20% to 80%–100%, causing severe sedation, respiratory depression, and encephalopathy.

Question 49Pharmacokinetics, therapeutic monitoring and explicit calculation models

Which listed developmental metabolic and clearance factors explain the particular chloramphenicol toxicity risk in neonates, without supplying a treatment or dosing instruction?

  1. Direct destruction of immature neonatal thyroid follicles
  2. Immune-mediated intravascular hemolysis via anti-erythrocyte IgA antibodies
  3. Immature neonatal hepatic UDP-glucuronosyltransferase (UGT) activity and low renal clearance lead to massive toxic drug accumulation, cardiovascular collapse, and cyanosis (新生儿肝脏葡萄糖醛酸转移酶发育不成熟导致代谢障碍与循环衰竭) Correct answer.
  4. Premature closure of the ductus arteriosus

Explanation

Grey Baby Syndrome (灰婴综合征) occurs in neonates and premature infants receiving chloramphenicol because: 1) Neonatal hepatic UDP-glucuronosyltransferase (UGT2B7) enzymes are immature and deficient; 2) Immature neonatal renal glomerular/tubular clearance fails to eliminate unchanged drug. Chloramphenicol accumulates to toxic levels (>50 mg/L), poisoning mitochondrial ribosomes, which triggers abdominal distension, vomiting, progressive flaccid hypothermia, ashen-grey cyanosis (灰婴), metabolic acidosis, and fatal cardiovascular collapse.

Question 50Pharmacokinetics, therapeutic monitoring and explicit calculation models

A patient stabilized on long-term Warfarin anticoagulation (target INR 2.0–3.0) is diagnosed with pulmonary tuberculosis and prescribed standard anti-TB therapy including Rifampin (利福平). What critical drug interaction must the clinical pharmacist anticipate?

  1. Rifampin strongly inhibits CYP2C9, precipitating severe systemic hemorrhages and INR >10
  2. Rifampin is a potent inducer of hepatic CYP2C9 and CYP3A4, dramatically accelerating warfarin metabolism and causing a severe drop in INR with thrombosis risk (利福平强诱导CYP2C9/3A4，加速华法林代谢，导致INR显著下降) Correct answer.
  3. Rifampin displaces warfarin from albumin, causing sudden fatal bleeding
  4. Rifampin has zero metabolic effect on oral anticoagulants

Explanation

Rifampin (利福平) is one of the most potent broad-spectrum inducers of hepatic Cytochrome P450 enzymes (including CYP2C9, CYP3A4, CYP1A2, CYP2C19) and P-glycoprotein. Because the more potent (S)-warfarin enantiomer is cleared by CYP2C9, rifampin increases warfarin clearance multi-fold, causing plasma warfarin concentrations to plummet and INR to drop far below therapeutic range within days, leading to stroke or thromboembolic recurrence unless warfarin dosage is substantially increased under frequent INR monitoring.